Premarket movers: LQDA settlement, BORR filing, ACN launch and BLK earnings

The alert lists LQDA up 40% after a global settlement resolving pending litigation with United Therapeutics and ensuring continued YUTREPIA commercialization in PAH. It also lists BORR up 4% after a Schedule 13D filing, ACN up 2.5% after launching a forward deployed engineering program with Workday, and BLK up 2.25% on earnings.